Carlsmed Raises FY2026 Sales Guidance from $74.000M-$78.000M to $78.000M-$80.000M vs $76.944M Est
Benzinga Newsdesk 8 hours ago
NewsGuidance
Carlsmed (NASDAQ:CARL) raises FY2026 sales outlook from $74.000 million-$78.000 million to $78.000 million-$80.000 million vs $76.944 million estimate.
Carlsmed (NASDAQ:CARL) raises FY2026 sales outlook from $74.000 million-$78.000 million to $78.000 million-$80.000 million vs $76.944 million estimate.